Results 71 to 80 of about 3,970 (233)

A Case of Extrapulmonary Tuberculosis Two-Ways [PDF]

open access: yes, 2019
Tuberculosis (TB) is a widespread epidemic. The World HealthOrganization estimated 10.4 million cases of tuberculosis in 2016,with 490,000 new cases of multi-drug resistant (MDR) TB.1 Theprimary presentation of TB is pulmonary.
Cherabie, Joseph   +2 more
core   +2 more sources

Implicación del fenotipo de cáncer de mama en pacientes con carcinomatosis leptomeníngea [PDF]

open access: yes, 2012
Aquest estudi permet conèixer les implicacions dels diferents subtipus de cáncer de mama: luminal A, luminal B, HER2+, triple negatiu en el desenvolupament y pronostic de la carcinomatosi leptomeníngea (CL).
Cortés Castán, Javier   +4 more
core  

Added Diagnostic Value of Cerebrospinal Fluid Carcinoembryonic Antigen in a Patient with Leptomeningeal Carcinomatosis as the Initial Manifestation of Gastric Cancer [PDF]

open access: yes, 2021
A 77-year-old woman with no history of malignancy presented with anorexia and bilateral lower extremity weakness. Her consciousness level worsened daily, so we performed a lumbar puncture.
Hashimoto, Daisuke   +6 more
core   +1 more source

Collecting Duct Meningeal Carcinomatosis

open access: yesArchives of Pathology & Laboratory Medicine, 1999
AbstractCollecting duct carcinoma (CDC) is an aggressive primary renal neoplasm that represents a distinct subtype of renal cell carcinoma. Histochemical (eg, mucicarmine) and immunohistochemical (eg, Ulex europaeus) studies, taken in concert with the gross and histologic findings, allow differentiation of CDC from the conventional varieties of renal ...
J W, Olivere   +3 more
openaire   +2 more sources

Clinical Features, Molecular Biology, and the Metastatic Microenvironment in Lung Cancer Brain Metastases: Implications for Treatment Decisions

open access: yesAdvanced Science, Volume 12, Issue 33, September 4, 2025.
Brain metastases (BM) from lung cancer are aggressive with poor prognosis. This review covers clinical features, diagnosis, early metastasis, and multi‐omics‐elucidated mechanisms, especially the tumor microenvironment of lung cancer with BM. It also discusses preclinical models, signaling pathways, and emerging therapies.
Yixiang Zhu   +5 more
wiley   +1 more source

Pyrotinib and Nab‐Paclitaxel in HER2‐Positive Breast Cancer (PANHER Trial): A Prospective, Single‐Arm, Phase II Trial

open access: yesCancer Science, Volume 116, Issue 7, Page 1920-1929, July 2025.
In this multicenter, single‐arm, open‐label phase II trial, patients with HER2‐positive breast cancer who had previously received chemotherapy with taxanes or anthracyclines were enrolled to receive pyrotinib combined with nab‐paclitaxel, and the results demonstrated promising efficacy with an acceptable safety profile.
Huan Li   +23 more
wiley   +1 more source

Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup phase III BIG 02-98 trial [PDF]

open access: yes, 2017
Background: Breast cancer central nervous system (CNS) metastases are an increasingly important problem because of high CNS relapse rates in patients treated with trastuzumab and/or taxanes. Patients and methods: We evaluated data from 2887 node-positive
Andersson, M.   +14 more
core  

Headache management for the pain specialist [PDF]

open access: yes, 2004
Headache is a common symptom caused by a wide variety of diseases. Primary headaches include migraine, cluster headache, tension-type headache and other less common diseases.
Ashkenazi, Avi, Silberstein, Stephen
core   +2 more sources

Clinical and Radiological Advances in Autoimmune GFAP Astrocytopathy: Analysis of 387 Patients in Japan

open access: yesClinical and Experimental Neuroimmunology, Volume 16, Issue 2, Page 174-187, May 2025.
ABSTRACT Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy (GFAP‐A) is an autoimmune inflammatory central nervous system disease. Recent neuropathological findings indicate that GFAP‐specific cluster of differentiation (CD)8+ T cells are likely the effectors of GFAP‐A.
Akio Kimura
wiley   +1 more source

Paraneoplastic necrotizing myopathy in a woman with breast cancer: a case report [PDF]

open access: yes, 2009
Introduction Paraneoplastic necrotizing myopathy is a rare disorder, described as a proximal, symmetrical, and rapidly progressing myopathy that is manifested as a paraneoplastic syndrome.
Silvestre Joana   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy